Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma
Authors
Keywords
-
Journal
Immunotherapy
Volume 13, Issue 3, Pages 217-225
Publisher
Future Medicine Ltd
Online
2020-11-26
DOI
10.2217/imt-2020-0265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
- (2019) O Hamid et al. ANNALS OF ONCOLOGY
- Real-world treatment patterns and clinical outcomes among patients with advanced melanoma
- (2019) C. Lance Cowey et al. MEDICINE
- Real-world experience with pembrolizumab in patients with advanced melanoma
- (2019) Frank Xiaoqing Liu et al. MEDICINE
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
- (2019) Reem Saleh et al. SEMINARS IN CANCER BIOLOGY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
- (2018) Danielle Benedict Sacdalan et al. OncoTargets and Therapy
- Using real world data to evaluate overall survival in PD1-treated vs. standard of care metastatic melanoma patients.
- (2018) Purvi Dev-Vartak et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies
- (2017) Alice Bernard-Tessier et al. EUROPEAN JOURNAL OF CANCER
- Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy
- (2017) Alvaro Moreira et al. Immunotherapy
- Eosinophils: The unsung heroes in cancer?
- (2017) Gilda Varricchi et al. OncoImmunology
- IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
- (2017) Valeria Lucarini et al. OncoImmunology
- Eosinophils in Cancer: Favourable or Unfavourable?
- (2016) Samy Sakkal et al. CURRENT MEDICINAL CHEMISTRY
- Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
- (2015) Rafael Carretero et al. NATURE IMMUNOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
- (2013) J. Delyon et al. ANNALS OF ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now